ZFIN Image: Wang et al., 2022, Fig. 6

Image

Figure Caption

Fig. 6

Combined inhibition of the TCA cycle and DNA methylation through CPI-613 and Bobcat 339 significantly decreases the tumor burden in zebrafish xenografts of human T-ALL. (A) Treatment of zebrafish xenografts with the TCA cycle inhibitor CPI-613 (2 μM) or TET1/2 inhibitor Bobcat339 (4 μM) resulted in a slightly decreased tumor burden, while combination treatment led to a significantly decreased tumor burden. (B) Quantification of the tumor fluorescence intensity in zebrafish xenografts is shown in (A). The data are presented as the mean ± s.e.m., and statistical differences are calculated using an unpaired two-tailed t-test with the vehicle as the control. Scale bar in (A) = 500 μm. * p < 0.05.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers